Prognosis and outcome of pregnancies exposed to renin-angiotensin system blockers

Prenat Diagn. 2012 Nov;32(11):1071-6. doi: 10.1002/pd.3960. Epub 2012 Aug 18.

Abstract

Objective: To study pregnancy outcomes and fetal renal prognosis markers in cases of exposure to renin-angiotensin system blockers.

Methods: We conducted a retrospective study of a series of 21 patients exposed to blockers of the renin-angiotensin system during pregnancy. Two markers were prenatally studied, fetal serum β2-microglobulin and amniotic fluid volume. Poor renal prognosis evaluation was based on postnatal glomerular filtration rate or on the presence of renal histologic lesions.

Results: Of the 21 fetuses, only one had a normal postnatal renal function at birth (oligohydramnios regression and normal β2-microglobulin). All fetuses with persistent oligohydramnios or β2-microglobulin ≥ 5 mg/L presented an adverse renal outcome.

Conclusion: Exposure to renin-angiotensin system blockers complicated by oligohydramnios is associated with a very poor outcome. We propose a prenatal management based on amniotic fluid volume monitoring and fetal serum β2-microglobulin. However, our preliminary results have to be confirmed by a larger study.

MeSH terms

  • Abortion, Eugenic
  • Adult
  • Amniotic Fluid / drug effects
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Female
  • Fetal Blood / chemistry
  • France / epidemiology
  • Gestational Age
  • Humans
  • Kidney / abnormalities
  • Kidney / drug effects
  • Kidney / physiopathology
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / diagnosis
  • Kidney Diseases / epidemiology
  • Kidney Failure, Chronic / chemically induced
  • Kidney Failure, Chronic / pathology
  • Kidney Failure, Chronic / physiopathology
  • Oligohydramnios / chemically induced*
  • Oligohydramnios / epidemiology
  • Oligohydramnios / pathology
  • Pregnancy
  • Pregnancy Outcome
  • Prenatal Exposure Delayed Effects / chemically induced*
  • Prenatal Exposure Delayed Effects / epidemiology
  • Prenatal Exposure Delayed Effects / pathology
  • Prognosis
  • Renin-Angiotensin System / drug effects*
  • Retrospective Studies
  • beta 2-Microglobulin / blood

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • beta 2-Microglobulin